{"id":45287,"date":"2022-06-21T09:01:47","date_gmt":"2022-06-21T07:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/"},"modified":"2022-06-21T09:01:47","modified_gmt":"2022-06-21T07:01:47","slug":"spectrumx-strengthens-senior-leadership","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/","title":{"rendered":"SpectrumX Strengthens Senior Leadership"},"content":{"rendered":"
\n

\nPharma and healthcare experts Dr Donna Lockhart and Greg Whelan join with newly created roles of Head of Medicines and Group Sales Director as business progresses<\/i>\n<\/p>\n

LONDON–(BUSINESS WIRE)–#appointments<\/a>–SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has strengthened its senior management team with Dr Donna Lockhart joining as Head of Medicines consultant and Greg Whelan being appointed as Group Sales Director. These newly created roles will support the company\u2019s growth as it progresses towards clinical trials and the commercial launch of its non-pharmaceutical products.\n<\/p>\n

<\/a><\/p>\n

\nDr Donna Lockhart \u2013 Head of Medicines<\/i><\/b>\n<\/p>\n

\nDr Donna Lockhart brings over 30 years\u2019 experience in the pharmaceutical industry, including having been Medical Director at Pfizer and Global Director of Regulatory and Medical Affairs at Reckitt Benckiser. She has significant know-how across pharmaceutical and medical device product development, medical affairs, clinical development, regulatory affairs, manufacturing and quality assurance. Donna obtained her medical degree at St. Mary\u2019s Hospital in London and spent 7 years in clinical practice. She is a GMC registered physician with a B.Sc. in Clinical Pharmacology and has a Master of Business Administration.\n<\/p>\n

\nIn the role of Head of Medicines, Donna is responsible for SpectrumX\u2019s clinical programmes, including directing the SPC-069 clinical trial, which is due to commence in the coming months. SPC-069 is a potential novel treatment, based on Hypochlorous Acid (\u201cHOCl\u201d), for respiratory infection and is the first drug candidate in the world with broad spectrum anti-pathogenic properties. Donna is also responsible for assessing the value and prospect of various other drug candidates of Spectrum Antimicrobials Inc., the US-based developer of proprietary formulations of HOCI and associated technologies for medical applications, with a view to entering future licencing agreements.\n<\/p>\n

\nGreg Whelan \u2013 Group Sales Director<\/i><\/b>\n<\/p>\n

\nGreg Whelan\u2019s career in the healthcare sector spans over 20 years with senior sales positions at blue-chip organisations such as GlaxoSmithKline, MSD and Omnicell as well as SME consultancies. He brings significant experience of launching products, in the UK and internationally, into private healthcare, pharmacy markets and the NHS. He has consulted extensively with the NHS, including projects across communications and engagement planning and strategy. Greg is also certified by the Association of the British Pharmaceutical Industry as a qualified and ethical Medical Representative.\n<\/p>\n

\nGreg is responsible for leading sales strategy and supporting sales delivery for the company\u2019s Spectricept\u2122 line of sanitisers \u2013 a product range aimed at hospitals and health facilities, businesses and retailers \u2013 and, following the receipt of regulatory approval in due course, its pharmaceutical products. Alongside the company\u2019s marketing director, he also oversees sales strategy for the spectriSKIN product range, which is sold direct to consumers.\n<\/p>\n

\nDamien Hancox, CEO & Co-Founder of Spectrum X, said<\/b>: \u201cWith our upcoming pharmaceutical clinical trials and launch of our non-pharmaceutical products, the addition of Donna and Greg will be of great value to SpectrumX. Donna\u2019s proven expertise in clinical drug development will be instrumental in ensuring that we are best positioned for success while Greg has an impressive record of aggressively growing sales. We look forward to benefiting from their experience as we continue to progress towards bringing our products to market.\u201d<\/i>\n<\/p>\n

\nDr Donna Lockhart, Head of Medicines at SpectrumX, added: <\/b>\u201cSpectrumX is developing innovative solutions to illnesses within the medical sphere and it is exciting to join such a progressive company. I am keen to get underway with the SPC-069 clinical trial programme along with the evaluation of new drug candidates that have the potential to play a substantial role in the treatment of serious illnesses.\u201d<\/i>\n<\/p>\n

\nGreg Whelan, Group Sales Director at SpectrumX, commented: <\/b>\u201cI am delighted to join the team at SpectrumX at this pivotal time as it approaches the commercial launch of its consumer HOCI-based products. I am very much looking forward to working with the incredible team and to market these ground-breaking solutions for the healthcare community.\u201d<\/i>\n<\/p>\n

\n– ENDS –\n<\/p>\n

\nAbout SpectrumX<\/b>\n<\/p>\n

\nSpectrumX is a UK-based healthcare and pharmaceuticals company focused on bringing to market a ground-breaking respiratory therapy (SPC-069) and the roll out of the most powerful hand sanitiser in the world to the NHS and other healthcare clients. Both products utilise unique patent pending HOCl formulations. HOCl is naturally occurring in human\u2019s white blood cells and is a key contributor to mankind\u2019s evolution and protection over millions of years. It is human safe whilst also being the most effective disinfectant known to mankind. To learn more about SpectrumX click here<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact<\/b>\n<\/p>\n

\nLuther Pendragon<\/b>
Jeff Segvich\/Claire Norbury\n<\/p>\n

\nspectrumx@luther.co.uk<\/a>
+44 (0)20 7618 9100\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pharma and healthcare experts Dr Donna Lockhart and Greg Whelan join with newly created roles of Head of Medicines and Group Sales Director as business progresses LONDON–(BUSINESS WIRE)–#appointments–SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has strengthened its senior management team with Dr Donna Lockhart joining as Head of Medicines consultant … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45287","6":"format-standard","7":"category-industry"},"yoast_head":"\nSpectrumX Strengthens Senior Leadership - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SpectrumX Strengthens Senior Leadership - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Pharma and healthcare experts Dr Donna Lockhart and Greg Whelan join with newly created roles of Head of Medicines and Group Sales Director as business progresses LONDON–(BUSINESS WIRE)–#appointments–SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has strengthened its senior management team with Dr Donna Lockhart joining as Head of Medicines consultant ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-21T07:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220621005309\/en\/1491540\/21\/SpectrumX_Logo_2022.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SpectrumX Strengthens Senior Leadership\",\"datePublished\":\"2022-06-21T07:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/\"},\"wordCount\":755,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220621005309\\\/en\\\/1491540\\\/21\\\/SpectrumX_Logo_2022.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/\",\"name\":\"SpectrumX Strengthens Senior Leadership - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220621005309\\\/en\\\/1491540\\\/21\\\/SpectrumX_Logo_2022.jpg\",\"datePublished\":\"2022-06-21T07:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220621005309\\\/en\\\/1491540\\\/21\\\/SpectrumX_Logo_2022.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220621005309\\\/en\\\/1491540\\\/21\\\/SpectrumX_Logo_2022.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/spectrumx-strengthens-senior-leadership\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SpectrumX Strengthens Senior Leadership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SpectrumX Strengthens Senior Leadership - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/","og_locale":"en_US","og_type":"article","og_title":"SpectrumX Strengthens Senior Leadership - Pharma Trend","og_description":"Pharma and healthcare experts Dr Donna Lockhart and Greg Whelan join with newly created roles of Head of Medicines and Group Sales Director as business progresses LONDON–(BUSINESS WIRE)–#appointments–SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has strengthened its senior management team with Dr Donna Lockhart joining as Head of Medicines consultant ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-21T07:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220621005309\/en\/1491540\/21\/SpectrumX_Logo_2022.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SpectrumX Strengthens Senior Leadership","datePublished":"2022-06-21T07:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/"},"wordCount":755,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220621005309\/en\/1491540\/21\/SpectrumX_Logo_2022.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/","url":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/","name":"SpectrumX Strengthens Senior Leadership - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220621005309\/en\/1491540\/21\/SpectrumX_Logo_2022.jpg","datePublished":"2022-06-21T07:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220621005309\/en\/1491540\/21\/SpectrumX_Logo_2022.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220621005309\/en\/1491540\/21\/SpectrumX_Logo_2022.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/spectrumx-strengthens-senior-leadership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SpectrumX Strengthens Senior Leadership"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45287"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45287\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}